Arvinas appoints Andrew Saik as CFO, effective June 24, 2024

ARVINAS, INC.

Andrew Saik, former Intercept Pharmaceuticals CFO, named permanent CFO at Arvinas.
Base salary of $525,000; annual bonus target of 45% of base salary.
Granted 94,418 options and 61,409 RSUs, both vesting over four years.
Randy Teel, Ph.D., who served as interim CFO, returns to chief business officer role.

item 5.02

ARVINAS, INC. filing history →

Source: SEC EDGAR

accession 0001655759-24-000101

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.